Is Palantir Stock Still Overvalued?

Palantir’s revenue growth is accelerating, with analysts forecasting 74% revenue growth next quarter and Q4 net income margins reaching a record 43%. However, the stock still trades at 231x trailing earnings and 111x forward earnings, which the article argues leaves years of growth already priced in. The author remains bearish on valuation and would need a much lower share price before considering a buy.

Analysis

The market is implicitly debating whether PLTR is a durable compounder or a momentum asset with a long-duration multiple problem. The key second-order effect is that when a stock already discounts years of perfect execution, even excellent quarters can underperform if they fail to extend the terminal growth runway; that makes the equity more sensitive to forward guidance quality than to current-quarter beats. In practice, the name is trading less like software and more like a long-dated call option on AI adoption across government and regulated enterprise.

The main beneficiary of PLTR’s strength is not just Palantir itself but the broader AI infrastructure stack: every additional AIP deployment validates enterprise AI budgets and keeps pressure on customers to modernize data layers, which is constructive for NVDA and, to a lesser extent, INTC as AI spend broadens beyond the hyperscaler capex cycle. The competitive risk is that PLTR’s high-profile wins may accelerate copycat offerings from larger platform vendors that can bundle AI into existing workflows at lower incremental price, compressing PLTR’s new-logo economics before it meaningfully displaces incumbents.

From a risk perspective, the near-term setup is asymmetric to any disappointment in billings, remaining performance obligations, or forward margin cadence over the next 1-2 quarters. At this valuation, even a modest deceleration in growth or a guide that implies normalization to sub-50% revenue growth could trigger multiple compression faster than fundamentals can deteriorate. The contrarian case is that the market may be underappreciating the persistence of government stickiness and the optionality of commercial expansion, but that optionality is already partially capitalized at a level that leaves little margin for error.

The better expression is probably not outright shorting PLTR blindly, but structuring downside exposure around earnings windows where implied expectations are highest and realized growth can gap on any small miss. If AI adoption remains broad, the ecosystem winners with lower embedded expectations may offer better risk/reward than PLTR itself. The stock is still a quality story, but the valuation leaves it one quarter away from becoming a de-rating candidate.

Key Decisions for Investors

• Avoid initiating a fresh long PLTR here; if already exposed, trim 25-50% into strength and retain only a core position through a 6-12 month horizon because the valuation leaves little tolerance for even one softer guide.
• For tactical downside, buy PLTR put spreads into the next earnings event (30-60 DTE), targeting a 10-15% downside move; risk/reward is attractive because implied volatility is likely cheaper than the multiple compression risk.
• Pair trade: long NVDA / short PLTR over the next 3-6 months if you want AI beta without paying extreme earnings power multiple; this expresses continued AI capex adoption while reducing idiosyncratic valuation risk.
• Consider a relative long INTC vs. short PLTR basket only if you expect AI infrastructure spend to broaden beyond the application layer; the trade benefits from valuation normalization in software while keeping some AI exposure.
• Set a hard risk trigger on PLTR if revenue growth decelerates sequentially or forward guidance slips below current Street expectations; that would be the cleanest catalyst for a 20-30% drawdown.